Federal contract award
75F40121P00322
DEVELOPMENT SOPS TO ENSURE VIRAL INACTIVATION IN TISSUE (MATERNAL VITAL ORGAN, MATERNAL REPRODUCTIVE ORGAN, EMBRYOS/FETUSES AND MATERNAL-FETAL INTERFACE TISSUES) AND BLOOD SAMPLES PRIOR TO SHIPMENT TO NCTR.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | B504 — Chemical/Biological Studies and Analysis |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $24.9K |
| Current contract value | $24.9K |
| Potential contract value / ceiling | $24.9K |
| Start date | Jul 8, 2021 |
| Current end date | Jul 7, 2022 |
| Potential end date | Jul 7, 2022 |
| Latest award activity | Oct 11, 2024 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Oct 11, 2024 | P00003 | $-0 | MODIFICATION TO INCORPORATE IPP CLAUSE |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.